Results 21 to 30 of about 3,702 (95)

The current status of chronic kidney disease-mineral and bone disorder management in China

Scientific Reports, 2022
Chronic kidney disease-mineral and bone disorder (CKD-MBD) is one of the most common complications of patients with chronic kidney disease (CKD). After considering updated international and domestic CKD-MBD management guidelines, the current management ...
Ya Zhan, Xin He, Daqing Hong, Li Wang, Guisen Li   +4 more
doaj   +1 more source

Chronic kidney disease patients who smoke have higher serum phosphorus

Brazilian Journal of Nephrology, 2018
Introduction: Mineral and bone metabolism disorders in chronic kidney disease (CKD-MBD) constitute a syndrome defined by changes in calcium, phosphorus (P), vitamin D and parathormone, fibroblast growth factor 23 (FGF-23) and its specific cofactor ...
Geuza Dutra dos Santos, Rosilene Motta Elias, Maria Aparecida Dalboni, Giovânio Vieira da Silva, Rosa Maria Affonso Moysés   +4 more
doaj   +1 more source

Carotid intima-media thickness, fibroblast growth factor 23, and mineral bone disorder in children with chronic kidney disease

BMC Nephrology
Background Carotid intima-media thickness (cIMT) is a measure of atherosclerotic vascular disease and a surrogate biomarker for cardiovascular risk in patients with chronic kidney disease (CKD).
Retno Palupi-Baroto, Kristia Hermawan, Indah Kartika Murni, Tiara Nurlita, Yuli Prihastuti, Ira Puspitawati, Chika Carnation Tandri, Cahyani Gita Ambarsari   +7 more
doaj   +1 more source

Prevalence of Mineral Bone Disease in Chronic Kidney Disease Patients using Biochemical Markers [PDF]

Journal of Clinical and Diagnostic Research, 2020
Introduction: Chronic Kidney Disease (CKD), a condition characterised by a gradual loss of renal function over the time, has emerged as a major public health concern with 17% prevalence in Indian population. Decrease in renal function in CKD leads to
Reeta Choudhary, Charu Yadav, Pallavi Jain, Shyam Bihari Bansal, Beena Bansal, Arun Kumar Harith   +5 more
doaj   +1 more source

Calciphylaxis: Beyond CKD-MBD

Nefrología (English Edition), 2017
Introduction: Calcific uraemic arteriolopathy (CUA), also called calciphylaxis, is a rare but potentially fatal vascular disorder that almost exclusively affects patients with chronic renal failure. The objective of this study was to analyse various risk
María Fernández, Enrique Morales, Eduardo Gutierrez, Natalia Polanco, Eduardo Hernández, Eva Mérida, Manuel Praga   +6 more
doaj   +1 more source

Management of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)

Jurnal Penyakit Dalam Indonesia, 2021
Chronic kidney disease (CKD) is still a burden on worldwide health issues affecting about 11-13% of the general population. Chronic kidney disease-mineral and bone disorder (CKD-MBD) is a common complication in CKD, which occurs early in the disease, and
Pringgodigdo Nugroho
doaj   +1 more source

Bone Disorders in Pediatric Chronic Kidney Disease: A Literature Review

Biology, 2023
Intense changes in mineral and bone metabolism are frequent in chronic kidney disease (CKD) and represent an important cause of morbidity and reduced quality of life. These disorders have conventionally been defined as renal osteodystrophy and classified
Lavinia Capossela, Serena Ferretti, Silvia D’Alonzo, Lorenzo Di Sarno, Valeria Pansini, Antonietta Curatola, Antonio Chiaretti, Antonio Gatto   +7 more
doaj   +1 more source

Association between proteinuria and mineral metabolism disorders in chronic kidney disease: the Japan chronic kidney disease database extension (J-CKD-DB-Ex)

Scientific Reports
Chronic kidney disease-mineral and bone disorder (CKD-MBD) are recognized as a systemic disease affecting the prognosis of patients with CKD. Proper management of CKD-MBD is important to improve the prognosis of patients with CKD. Although proteinuria is
Sho Shimamoto, Takako Nakahara, Shunsuke Yamada, Hajime Nagasu, Seiji Kishi, Naoki Nakashima, Kazuhiko Tsuruya, Hirokazu Okada, Kouichi Tamura, Ichiei Narita, Shoichi Maruyama, Yuichiro Yano, Takashi Yokoo, Takashi Wada, Jun Wada, Eiichiro Kanda, Hiromi Kataoka, Masaomi Nangaku, Naoki Kashihara, Toshiaki Nakano   +19 more
doaj   +1 more source

Augmented Fibroblast Growth Factor-23 Secretion in Bone Locally Contributes to Impaired Bone Mineralization in Chronic Kidney Disease in Mice

Frontiers in Endocrinology, 2018
Chronic kidney disease-mineral and bone disorder (CKD-MBD) is a systemic disorder of mineral and bone metabolism caused by CKD. Impaired bone mineralization together with increased bony secretion of fibroblast growth factor-23 (FGF23) are hallmarks of ...
Olena Andrukhova, Christiane Schüler, Claudia Bergow, Alexandra Petric, Reinhold G. Erben   +4 more
doaj   +1 more source

Association between serum phosphate levels and anemia in non-dialysis patients with chronic kidney disease: a retrospective cross-sectional study from the Fuji City CKD Network

BMC Nephrology, 2023
Background Patients with chronic kidney disease (CKD) present high mortality and morbidity rates despite the availability of various therapies. Although CKD-mineral and bone disorder (MBD) and renal anemia are important factors in patients with CKD, only
Kazuhiko Kato, Akio Nakashima, Ichiro Ohkido, Kenji Kasai, Takashi Yokoo   +4 more
doaj   +1 more source